As Director of Study Operations, Alexis Rejeski oversees daily operations of the creation and maintenance of study builds for Clinical Ink customers. She brings over 20 years of clinical trial planning and conduct experience, as well as expertise in development of psychophysiological interventions, biotechnology, and information technology. Her operational background includes implementation of continuous improvement, operational risk management, and quality management systems.
At KeraNetics, Alexis served on the executive management team and brought two technologies from benchtop to commercial readiness. She holds an MBA from Wake Forest University School of Business.